Sunday, Sep 20, 2020 | Last Update : 07:46 PM IST

180th Day Of Lockdown

Maharashtra118801585793332216 Andhra Pradesh6177765307115302 Tamil Nadu5364774812738751 Karnataka5113454048417922 Uttar Pradesh3362942632884771 Delhi2347011981034877 West Bengal2155801870614183 Telangana1713061397001033 Odisha167161133466722 Bihar164224149722855 Assam150349121610528 Kerala12221687341490 Gujarat119088999083271 Rajasthan109088906851293 Haryana103773816901069 Madhya Pradesh97906743981877 Punjab90032658182646 Chhatisgarh7777541111628 Jharkhand6710052807590 Jammu and Kashmir5971138521951 Uttarakhand3713924810460 Goa2678320844327 Puducherry2142816253431 Tripura2069612956222 Himachal Pradesh11190691997 Chandigarh92566062106 Manipur8430653951 Arunachal Pradesh6851496713 Nagaland5306407910 Meghalaya4356234232 Sikkim2119178923 Mizoram15069490
  India   All India  06 May 2019  Govt, CSIR pact on ayurveda research

Govt, CSIR pact on ayurveda research

THE ASIAN AGE. | RAHUL CHHABRA
Published : May 6, 2019, 3:18 am IST
Updated : May 6, 2019, 3:18 am IST

CSIR labs have already produced anti-diabetic drug BGR-34

The CSIR director said the MoU will also help in development of international standardised terminologies (disease-morbidity codes) in ayurveda, siddha and unani. (Representational image)
 The CSIR director said the MoU will also help in development of international standardised terminologies (disease-morbidity codes) in ayurveda, siddha and unani. (Representational image)

New Delhi: Auguring well for research in ayurveda and other traditional systems of medicine, the Union ministry of Ayush and the Council of Scientific and Industrial Research (CSIR) have joined hands to help integrate modern scientific methods with Indian’s centuries-old knowledge and promote herbal products.

An agreement for this purpose was recently signed by Union Ayush secretary Vaidya Rajesh Kotecha and CSIR director Shekhar C. Mande.

 

In the past, too, CSIR labs have undertaken research, along the Central Institute of Medicinal and Aromatic Plants (CIMAP) and the National Botanical Research Institute (NBRI), to jointly develop anti-diabetic herbal drug BGR-34. The scientifically validated poly-herbal ayurvedic blood glucose regulator BGR-34, marketed by marketed by Delhi-based AIMIL Pharmaceuticals, has been prepared from six medicinal plants. Mr Kotecha said that a combination of traditional healthcare and modern basic science has a huge potential for path-breaking research.

As per the latest MoU, the ministry and the CSIR will pursue R&D on ayush specific diagnostic tools and multi-ingredient herbal formulations, including their standardisation. Collaboration in preserving and protecting traditional knowledge related to the Indian systems of healthcare will also be strengthened, said a ministry statement.

 

Mr Mande said that enhancing the collaboration with the ministry through joint R&D efforts ranging from fundamental science to validation and, thereafter, product development will significantly help in the growth of the Indian contribution to the herbal drugs sector, not only nationally but also internationally.

He expressed confidence that the partnership with the ministry will help boost the prospects of Indian herbal products in quality-conscious domestic as well as global market.

The CSIR director said the MoU will also help in development of international standardised terminologies (disease-morbidity codes) in ayurveda, siddha and unani.

 

Tags: csir, ayurveda